Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study
暂无分享,去创建一个
J. Ji | Anqiang Wang | Z. Bu | K. Ji | Jiahui Chen
[1] L. Xue,et al. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach , 2020, Journal of Cancer Research and Clinical Oncology.
[2] Guoxin Li,et al. Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next? , 2019, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[3] L. Shen,et al. Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm , 2019, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[4] Haitao Zhao,et al. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma , 2019, EBioMedicine.
[5] Chang-ming Huang,et al. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients , 2018, BMC Cancer.
[6] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[7] R. van Hillegersberg,et al. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] P. Ruszniewski,et al. Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms , 2017, Neuroendocrinology.
[9] R. Lloyd,et al. WHO classification of tumours of endocrine organs , 2017 .
[10] Y. S. Park,et al. Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma , 2017, Therapeutic advances in gastroenterology.
[11] C. Compton,et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.
[12] D. Coit,et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project , 2017, Gastric Cancer.
[13] M. Hsieh,et al. A nationwide cohort study , 2016 .
[14] F. Sessa,et al. Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms , 2016, Endocrine Pathology.
[15] M. Poetsch,et al. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer. , 2015, World journal of gastroenterology.
[16] A. Nicholson,et al. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] Yoon-Koo Kang,et al. Prognostic significance of neuroendocrine components in gastric carcinomas. , 2014, European journal of cancer.
[18] M. Fassan,et al. Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components , 2014, Neuroendocrinology.
[19] D. Lambrechts,et al. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. , 2014, Anticancer research.
[20] H. Tsuda,et al. Neuroendocrine Carcinoma of the Stomach: Morphologic and Immunohistochemical Characteristics and Prognosis , 2013, The American journal of surgical pathology.
[21] F. Penault-Llorca,et al. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases , 2012, European journal of gastroenterology & hepatology.
[22] R. Talamini,et al. Exocrine and endocrine modulation in common gastric carcinoma. , 2012, American journal of clinical pathology.
[23] F. Sessa,et al. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update , 2012, Cancers.
[24] A. Vanoli,et al. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. , 2011, Human pathology.
[25] Zu-hua Gao,et al. Colorectal Glandular-Neuroendocrine Mixed Tumor: Pathologic Spectrum and Clinical Implications , 2011, The American journal of surgical pathology.
[26] M. Papotti,et al. Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas , 2010, Virchows Archiv.
[27] M. Saegusa,et al. Gastric Large Cell Neuroendocrine Carcinomas: A Distinct Clinicopathologic Entity , 2006, The American journal of surgical pathology.
[28] C. V. D. van de Velde,et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.
[29] Z. Qian,et al. Histological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomach. , 2005, The journal of medical investigation : JMI.
[30] Seung‐Mo Hong,et al. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. , 2005, Human pathology.
[31] Elisabeth Brambilla,et al. Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .
[32] Y. Ajioka,et al. Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration , 2003, Gastric Cancer.
[33] A. Iwashita,et al. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma. , 2003, Anticancer research.
[34] G. Pelosi,et al. Microallelotyping Defines the Monoclonal or the Polyclonal Origin of Mixed and Collision Endocrine-Exocrine Tumors of the Gut , 2003, Laboratory Investigation.
[35] H. Matsubayashi,et al. Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy , 2000, Gastric Cancer.
[36] E. Furth,et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. , 1997, Journal of the National Cancer Institute.
[37] M. Rhyu,et al. Genetic evidence for the multi-step progression of mixed glandular–neuroendocrine gastric carcinomas , 2014, Virchows Archiv.
[38] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[39] W. Travis. Pathology & Genetics Tumours of the lung, Pleura, Thymus and Heart , 2004 .
[40] T. Stijnen,et al. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction. , 2004, International journal of surgical pathology.
[41] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[42] J. Cooper. Ajcc Cancer Staging Manual , 1997 .
[43] J. A. Sulbarán Muñoz,et al. [Neuroendocrine neoplasms of the digestive system]. , 1990, G.E.N.